Risk of metastasis and survival in patients with T1-2 non-ampullary duodenal neuroendocrine tumors undergoing different treatment strategies
Cheng Peng, Wan-shu Chen, Yao-wen Hu, Tian-ming Xu, Peng-guang Yan, Xiang Xu, Bo-wen Tian, Ji Li, Jing-nan Li · 2026
Read Risk of metastasis and survival in patients with T1-2 non-ampullary duodenal neuroendocrine tumors undergoing different treatment strategies by Cheng Peng, Wan-shu Chen, Yao-wen Hu, Tian-ming Xu, Peng-guang Yan, Xiang Xu, Bo-wen Tian, Ji Li, Jing-nan Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13201687.txt.
Description
BackgroundOptimal management of T1-2 non-ampullary duodenal neuroendocrine tumors (NAD-NETs) remains controversial, particularly for intermediate-sized tumors (11–20 mm), due to limited evidence. This study aimed to quantify real-world metastasis risk and compare long-term survival after endoscopic therapy (ET) or surgical therapy (ST) for T1-2N0M0 NAD-NETs.
Catalog record
| CREATOR | Cheng Peng, Wan-shu Chen, Yao-wen Hu, Tian-ming Xu, Peng-guang Yan, Xiang Xu, Bo-wen Tian, Ji Li, Jing-nan Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |